Theravasc Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Theravasc Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013997
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases and diabetic neuropathy. Its TV1001SR is non-addicting, non-sedating, and has a mechanism of action to treat pain. Theravasc conducts research programs in peripheral artery diseases and wound healing. The company’s product with sodium nitrite, referenced to stimulate the re-growth of blood vessels in ischemic tissues. Theravasc is headquartered in Cleveland, Ohio, the US.

Theravasc Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Theravasc Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Theravasc Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Theravasc Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Theravasc Secures Venture Funding from Rev1 Ventures 10
Theravasc Raises USD0.4 Million in Venture Financing 11
Theravasc Raises US$0.2 Million In Venture Financing 12
Theravasc Inc – Key Competitors 13
Theravasc Inc – Key Employees 14
Theravasc Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Theravasc Inc, Pharmaceuticals & Healthcare, Key Facts 2
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Theravasc Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Theravasc Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Theravasc Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Theravasc Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Theravasc Secures Venture Funding from Rev1 Ventures 10
Theravasc Raises USD0.4 Million in Venture Financing 11
Theravasc Raises US$0.2 Million In Venture Financing 12
Theravasc Inc, Key Competitors 13
Theravasc Inc, Key Employees 14

★海外企業調査レポート[Theravasc Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), is a pharmaceutical company that provides compounding solutions. The company offers products such as raw materials, flammable products, extracts and tinctures; anesthetic, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards sys …
  • Kyochon F&B Co., Ltd.:企業の戦略・SWOT・財務分析
    Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kyochon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Biomatrica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Terracon Consultants Inc:企業のM&A・事業提携・投資動向
    Terracon Consultants Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Terracon Consultants Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Warrnambool Cheese and Butter Factory Company Holdings Limited:企業の戦略・SWOT・財務情報
    Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Warrnambool Cheese and Butter Factory Company Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report cov …
  • Galera Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical-stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • BC Technical Inc:医療機器:M&Aディール及び事業提携情報
    Summary BC Technical Inc (BC Technical), a subsidiary of Alpha Source Inc is a medical device company that provides molecular imaging solutions. The company offers spare parts for new and refurbished nuclear medicine equipments for gamma cameras and BC backup server. It provides PET, PET/CT, NM, SPE …
  • Superior Energy Services Inc (SPN):企業の財務・戦略的SWOT分析
    Superior Energy Services Inc (SPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野:企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …
  • Archroma Management GmbH:企業の戦略的SWOT分析
    Archroma Management GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Shopper’s Stop Ltd.:戦略・SWOT・企業財務分析
    Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CRH public limited company (CRG):企業の財務・戦略的SWOT分析
    CRH public limited company (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Starkey Hearing Technologies Inc:企業の戦略的SWOT分析
    Starkey Hearing Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Standard Bank Group Ltd (SBK):企業の財務・戦略的SWOT分析
    Standard Bank Group Ltd (SBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Standard Chartered Bank – India Branches:企業の戦略・SWOT・財務情報
    Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • AEON Co Ltd (8267):企業の財務・戦略的SWOT分析
    AEON Co Ltd (8267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Luminus Devices Inc:電力:M&Aディール及び事業提携情報
    Summary Luminus Devices Inc (Luminus Devices), a subsidiary of Lightera Corp is a lighting product manufacturer that develops and manufactures solid state light sources for illumination applications. The company provides products such as COB arrays, mid power LEDs, high brightness, white LEDs, color …
  • Bio3 Research Srl-製薬・医療分野:企業M&A・提携分析
    Summary Bio3 Research Srl (Bio3 Research) is a biopharmaceutical company that undertakes the identification and development of therapeutic agents for diseases related to HMGB1 protein over-expression and HMGB1 biological properties. The company develops proprietary compounds with therapeutic potenti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆